UV-irradiated grapefruit juice loses pharmacokinetic interaction with nifedipine in rats

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 6, 2006, Pages 1286-1289

  Uesawa, Yoshihiro ^a   Mohri, Kiminori ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Furanocoumarin; Grapefruit juice; Nifedipine; Pharmacokinetic interaction; UV irradiation

Indexed keywords

6',7' DIHYDROXYBERGAMOTTIN; BERGAMOTTIN; BERGAPTOL; FUROCOUMARIN DERIVATIVE; NIFEDIPINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DUODENUM; FOOD DRUG INTERACTION; GRAPEFRUIT JUICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MALE; NONHUMAN; RAT; ULTRAVIOLET IRRADIATION;

ANIMALS; BEVERAGES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITRUS PARADISI; DRUG INTERACTIONS; FOOD-DRUG INTERACTIONS; MALE; NIFEDIPINE; PSORALENS; RATS; RATS, WISTAR; ULTRAVIOLET RAYS;

EID: 33744921064     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1286     Document Type: Article

References (27)

1. Bailey D. G., Dresser G. K., Am. J. Cardiovasc. Drugs, 4, 281-297 (2004).
2. Bailey D. G., Spence J. D., Edgar B., Bayliff C. D., Arnold J. M., Clin. Invest. Med., 12, 357-362 (1989).
3. Sagir A., Schmitt M., Dilger K., Häussinger D., Digestion, 68, 41-48 (2003).
4. Kane G. C., Lipsky J. J., Mayo Clin. Proc., 75, 933-942 (2000).
5. He K., Iyer K. R., Hayes R. N., Sinz M. W., Woolf T. F., Hollenberg P. F., Chem. Res. Toxicol., 11, 252-259 (1998).
6. Malhotra S., Bailey D. G., Paine M. F., Watkins P. B., Clin. Pharmacol. Ther., 69, 14-23 (2001).
7. Kakar S. M., Paine M. F., Stewart P. W., Watkins P. B., Clin. Pharmacol. Ther., 75, 569-579 (2004).
8. Goosen T. C., Cillie D., Bailey D. G., Yu C., He K., Hollenberg P. F., Woster P. M., Cohen L., Williams J. A., Rheeders M., Dijkstra H. P., Clin. Pharmacol. Ther., 76, 607-617 (2004).
9. Paine M. F., Criss A. B., Watkins P. B., Drug Metab. Dispos., 32, 1146-1153 (2004).
10. Paine M. F., Criss A. B., Watkins P. B., J. Pharmacol. Exp. Ther., 312, 1151-1160 (2005).
11. Guo L. Q., Taniguchi M., Xiao Y. Q., Baba K., Ohta T., Yamazoe Y., Jpn. J. Pharmacol., 82, 122-129 (2000).
12. Mohri K., Uesawa Y., Pharm. Res., 18, 177-182 (2001).
13. Lerner A. B., Cleveland J., Denton R., Fitzpatrick T. B., J. Invest. Dermatol., 20, 299-314 (1953).
14. Fowlks W. L., J. Invest. Dermatol., 32, 249-314 (1959).
15. Knudsen E. A., Bech-Thomsen N., Wulf H. C., Photodermatol. Photoimmunol. Photomed., 11, 131-133 (1995).
16. Morlière P., Hüppe G., Averbeck D., Young A. R., Santus R., Dubertret L., J. Photochem. Photobiol. B, 7, 199-208 (1990)
17. Abou Elzahab M., Pharmazie, 48, 144-145 (1993).
18. Yamaoka K., Nakagawa T., J. Pharmacobio-Dyn., 6, 595-606 (1983).
19. Yamaoka K., Nakagawa T., Uno T., J. Pharmacokinet. Biopharm., 6, 547-558 (1978).
20. Ameer B., Weintraub R. A., Clin. Pharmacokinet., 33, 103-121 (1997).
21. Simon J. C., Pfieger D., Schopf E., Eur. J. Dermatol., 10, 642-645 (2000).
22. Koenigs L. L., Trager W. F., Biochemistry, 37, 10047-10061 (1998).
23. Koenigs L. L., Trager W. F., Biochemistry, 37, 13184-13193 (1998).
24. Koenigs L. L., Peter R. M., Thompson S. J., Rettie A. E., Trager W. F., Drug Metab. Dispos., 25, 1407-1415 (1997).
25. Mohri K., Uesawa Y., Sagawa K., Drug Metab. Dispos., 28, 482-486 (2000).
26. Lown K. S., Bailey D. G., Fontana R. J., Janardan S. K., Adair C. H., Fortlage L. A., Brown M. B., Guo W., Watkins P. B., J. Clin. Invest., 99, 2545-2553 (1997).
27. Okamoto Y., Environ. Mutagen Res., 23, 73-81 (2001).